Year archive

Hyloris Pharmaceuticals SA — 2026 filings

All 30 regulatory filings released by Hyloris Pharmaceuticals SA (HYL) in 2026, sourced directly from the official regulator.

30 Filings

2026 Period

2026 filings (30)

Filing	Released	Lang
10_Hyloris Pharma STAT_ PIE - BE Rapport comptes statutaires FR_SIGNED_300426.pdf Regulatory Filings	2026-05-08	French
8_2025 12 31 - Hyloris Pharmaceuticals - Rapport de Gestion FR - Signé.pdf Regulatory Filings	2026-05-08	French
6_Remuneration Policy 2026_Hyloris Pharmaceuticals_Update for GA 2026_translated FR_20260508.pdf Regulatory Filings	2026-05-08	French
Hyloris_Communique Presse_Convocation Assemblee Generale_FR_20260508.pdf Regulatory Filings	2026-05-08	French
7_Hyloris Pharmaceuticals BNB 31 12 2025_FR_FV.pdf Regulatory Filings	2026-05-08	French
1.b. Hyloris-CEO_Shareholder_Letter_GM2026_ENFR.pdf Regulatory Filings	2026-05-08	French
5_HYLORIS_RA25_GrandOuest-FR-Remuneration Report-260430.pdf Regulatory Filings	2026-05-08	French
3_Hyloris Pharmaceuticals SA - Proxy (FR)_GM 9 June 2026_20260508.pdf Regulatory Filings	2026-05-08	French
9_Hyloris Pharma_PIE - IFRS Report conso financial statements_FR_SIGNED_300426.pdf Regulatory Filings	2026-05-08	French
2_Hyloris Pharmaceuticals SA - Vote by letter form (FR)_GM 9 June 2026_20260508.pdf Regulatory Filings	2026-05-08	French
1_Hyloris Pharmaceuticals SA - Convening Notice Shareholders (EN)_GM 9 June 2026.pdf Regulatory Filings	2026-05-08	English
1_Hyloris Pharmaceuticals SA - Convening Notice Shareholders (FR)_GM 9 June 2026.pdf Regulatory Filings	2026-05-08	French
Hyloris_Press Release_Annual Report 2025_EN_20260330.pdf Regulatory Filings	2026-04-30	English
Hyloris_Communique Presse_Rapport_Annuel 2025_FR_20260430.pdf Regulatory Filings	2026-04-30	French
HYLORIS_RA25_Annual Report 2025_EN_20260430_FV.pdf Regulatory Filings	2026-04-30	English
HYLORIS_RA25_Rapport Annuel 2025_FR_20260430_FV.pdf Regulatory Filings	2026-04-30	French
875500LZIWS7QEQE0I73-2025-12-31-1-fr.zip Annual Report (ESEF) FY 2025	2026-04-30	French
875500LZIWS7QEQE0I73-2025-12-31-1-fr.xhtml Annual Report FY 2025	2026-04-30	French
Press Release_Hyloris_Update Denominator_EN_20260330.pdf Regulatory Filings	2026-03-31	English
Communique Presse_Hyloris_Update Denominator_FR_20260330.pdf Share Issue/Capital Change	2026-03-31	French
Hyloris_Press Release_Year Results 2025_EN_20260326_FV.pdf Earnings Release FY 2025	2026-03-26	English
Hyloris_Communique Presse _ Resultats Annuel 2025_FR_20260326_FV.pdf Earnings Release FY 2025	2026-03-26	French
Press Release_Hyloris_Update Valacyclovir Oral Solution_EN_20260219_FV.pdf Regulatory Filings	2026-02-19	English
Communique Presse_Hyloris_Update Valacyclovir Oral Solution_FR_20260219_FV.pdf Regulatory Filings	2026-02-19	French
Press Release_Hyloris_Notification received_EN_20260202_FV.pdf Major Shareholding Notification	2026-02-02	English
Press Release_Hyloris_Reception Notification_FR_20260202_FV.pdf Major Shareholding Notification	2026-02-02	French
Press Release_Hyloris_Update Denominator_EN_20260202.pdf Share Issue/Capital Change	2026-02-02	English
Communique Presse_Hyloris_Update Denominator_FR_20260202.pdf Share Issue/Capital Change	2026-02-02	French
Press Release_Hyloris_Orion_Panto_RTU_Europe_EN_20260119.pdf Regulatory Filings	2026-01-19	English
Communique Presse_Hyloris_Orion_Panto_RTU_Europe_FR_20260119.pdf Regulatory Filings	2026-01-19	French